You can:
Name | P2Y purinoceptor 2 |
---|---|
Species | Homo sapiens (Human) |
Gene | P2RY2 |
Synonym | Purinergic receptor purinergic receptor P2Y P2Y2 receptor P2Y2 P2Y purinoceptor 2 [ Show all ] |
Disease | Dry eye disease Constipation Cystic fibrosis Lung cancer |
Length | 377 |
Amino acid sequence | MAADLGPWNDTINGTWDGDELGYRCRFNEDFKYVLLPVSYGVVCVPGLCLNAVALYIFLCRLKTWNASTTYMFHLAVSDALYAASLPLLVYYYARGDHWPFSTVLCKLVRFLFYTNLYCSILFLTCISVHRCLGVLRPLRSLRWGRARYARRVAGAVWVLVLACQAPVLYFVTTSARGGRVTCHDTSAPELFSRFVAYSSVMLGLLFAVPFAVILVCYVLMARRLLKPAYGTSGGLPRAKRKSVRTIAVVLAVFALCFLPFHVTRTLYYSFRSLDLSCHTLNAINMAYKVTRPLASANSCLDPVLYFLAGQRLVRFARDAKPPTGPSPATPARRRLGLRRSDRTDMQRIEDVLGSSEDSRRTESTPAGSENTKDIRL |
UniProt | P41231 |
Protein Data Bank | N/A |
GPCR-HGmod model | P41231 |
3D structure model | This predicted structure model is from GPCR-EXP P41231. |
BioLiP | N/A |
Therapeutic Target Database | T93515 |
ChEMBL | CHEMBL4398 |
IUPHAR | 324 |
DrugBank | BE0002401 |
Name | CID 136908877 |
---|---|
Molecular formula | C29H17ClN7Na3O11S3 |
IUPAC name | trisodium;1-amino-4-[4-[[6-chloro-4-(3-sulfonatophenyl)imino-1H-1,3,5-triazin-2-ylidene]amino]-3-sulfonatoanilino]-9,10-dioxoanthracene-2-sulfonate |
Molecular weight | 840.092 |
Hydrogen bond acceptor | 15 |
Hydrogen bond donor | 4 |
XlogP | None |
Synonyms | N/A |
Inchi Key | VZPXDCIISFTYOM-UHFFFAOYSA-K |
Inchi ID | InChI=1S/C29H20ClN7O11S3.3Na/c30-27-35-28(33-13-4-3-5-15(10-13)49(40,41)42)37-29(36-27)34-18-9-8-14(11-20(18)50(43,44)45)32-19-12-21(51(46,47)48)24(31)23-22(19)25(38)16-6-1-2-7-17(16)26(23)39;;;/h1-12,32H,31H2,(H,40,41,42)(H,43,44,45)(H,46,47,48)(H2,33,34,35,36,37);;;/q;3*+1/p-3 |
PubChem CID | 136908877 |
ChEMBL | CHEMBL223344 |
IUPHAR | N/A |
BindingDB | N/A |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. Partition coefficient log P of this ligand is not available. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | <100000.0 nM | PMID12213051 | ChEMBL |
IC50 | <100000.0 nM | PMID19419204 | ChEMBL |
IC50 | 1000.0 nM | PMID19419204 | ChEMBL |
IC50 | 1050.0 nM | PMID19419204 | ChEMBL |
IC50 | 1570.0 nM | PMID19419204 | ChEMBL |
IC50 | 1620.0 nM | PMID19419204 | ChEMBL |
IC50 | 1850.0 nM | PMID19419204, PMID18006312, PMID20146483, PMID21207957 | ChEMBL |
IC50 | 9300.0 nM | PMID19419204 | ChEMBL |
IC50 | 12000.0 nM | PMID18630897 | ChEMBL |
IC50 | 18600.0 nM | PMID19419204 | ChEMBL |
Inhibition | 55.0 % | PMID19419204 | ChEMBL |
Ratio IC50 | 0.6 - | PMID19419204 | ChEMBL |
Ratio IC50 | 10.0 - | PMID19419204 | ChEMBL |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218